Here are four things to know.
1. Hydromorphone HCl is an opioid used to manage severe pain when alternative treatments prove inadequate.
2. Hospira distributed the affected products to wholesalers, distributors, retailers and hospitals nationwide between October 2016 and July 2017.
3. The cracked vials could render the drug product unsterile, putting patients at risk for infection. Healthcare professionals could also cut their hands when handling the cracked glass vials.
4. Hospira has not received any reports of adverse events related to the affected products.
More articles on supply chain:
Teva shutters offices in New York City, Washington D.C., as part of cost cutting plan
AbbVie, Biogen pull multiple sclerosis drug from the market citing safety concerns: 4 things to know
Why hospitals should look to drug utilization, not price, for continued cost savings
